SkyQuest Technology Group has recently published a comprehensive Addiction Treatment Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. The addiction treatment market is going through rapid growth because of the increasing awareness about the treatments and rising prevalence of addiction problems. Furthermore, rising initiatives from government like drug awareness campaigns and prevention programs are also boosting the addiction treatment market growth during the forecast period. Addiction mainly happens due to excessive use of illegal drugs, prescription or over-the-counter drugs or alcohol.
Addiction Treatment Market size was valued at USD 5.4 Billion in 2023 and is poised to grow from USD 5.71 Billion in 2024 to USD 8.96 Billion by 2032, growing at a CAGR of 5.80% during the forecast period (2025-2032).
For treating symptoms and reducing cravings related to substance use disorders various types of medications are employed. Some of the medicines that are used consist of methadone, buprenorphine, naltrexone, and disulfiram. Moreover, for treating the primary behavioral patterns that contribute to the addiction treatments are family therapy, contingency management, motivational interviewing, and cognitive behavioral therapy (CBT). The utilization of telemedicine, digital health technologies, and mobile health applications in addiction treatment is increasing opportunities in the field and enhancing program efficiency. Furthermore, the rise in insurance coverage for addiction treatment is also minimizing the expense of these services and increasing accessibility to more people, resulting in the growth of the market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/addiction-treatment-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Addiction Treatment Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Addiction Treatment Market is segmented by Type, Drug Type, Treatment Centers, Distribution Channel, and region.
Based on Type, the market is segmented into Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Others.
Based on Drug Type, the market is segmented into Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others.
Based on Treatment Centers, the market is segmented into Residential Treatment Centers, Outpatient Treatment Centers, and Inpatient Treatment Centers.
Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Addiction Treatment Market – Regional Analysis:
North America is dominating with the largest addiction treatment market share. One of the main drivers contributing to the rising demand for addiction treatment services is the increasing incidence of substance use, whether that be alcohol, illicit drugs, or opioids. Nowadays, there are government programs and schemes to curb substance use and assistance to these recovering from addiction is leading to the growth of this industry as well.
The Asia-Pacific market is witnessing the fastest growth in the addiction treatment market. Factors like rising awareness regarding substance use, government sponsorship, and growing treatment centers are contributing to the growth of addiction treatment market in the Asia Pacific. With growing evidence of increased misuse of substances such as alcohol, tobacco and illicit drugs, effective treatment alternatives are urgently required in many of the countries in the Asia Pacific region.
Top Market Players in Addiction Treatment Market are:
Alkermes plc (Ireland)
Dr. Reddy’s Laboratories Ltd. (India)
Hikma Pharmaceuticals plc (UK)
Indivior PLC (UK)
Mallinckrodt Pharmaceuticals (Ireland)
Orexo AB (Sweden)
Pear Therapeutics (US) Inc. (US)
Pfizer Inc. (US)
Viatris Inc. (US)
American Addiction Centers, Inc. (US)
Quest Diagnostics, Inc. (US)
Sage Therapeutics, Inc. (US)
Gilead Sciences, Inc. (US)
Acadia Pharmaceuticals Inc. (US)
Medications for Addiction Treatment (MAT) (US)
Intra-Cellular Therapies, Inc. (US)
Emergent BioSolutions Inc. (US)
Hims & Hers Health, Inc. (US)
Lundbeck A/S (Denmark)
Cambrex Corporation (US)
Caron Treatment Centers (US)
Smart Recovery (US)
Recovery Brands (US)
Recent Developments:
In May 2023, Camurus AB, a Swedish science-driven biopharma company, announced that Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe opioid use disorder (OUD).
On May 14, 2024, Lifespan Health System announced a new addiction treatment program aiming to provide same-day assistance to patients. It’s called Addiction Care Today, and it aims to provide walk-in and same-day appointments to people seeking to start treatment for substance use disorders.
In February 2024, Union Council of Ministers had announced that they had launched 41 dedicated addiction treatment facilities for drug addicts in Delhi. These facilities will free of cost treat, counsel and provide free medicines to the people who are addicted to drugs or other substances.
You may Also Like
https://issuu.com/skyquest-technology/docs/is_stearyl_alcohol_market_set_to_expand_with_risin
https://issuu.com/skyquest-technology/docs/is_the_home_beer_brewing_machine_market_revolution/s/88273697
Forward-Looking Insights
The Addiction Treatment Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
